Danish wind turbine company Vestas Wind Systems on Wednesday reported an increase in its profit for the fourth quarter of ...
Sales of Novo Nordisk’s (NVO) blockbuster weight-loss drug Wegovy doubled in the fourth quarter, but the Danish ...
The Danish group's after-tax profit jumped from 77 million euros in 2023 to 499 million euros ($520 million) last year.
The founder of the Rains fashion brand has restored a 19th-century industrialist’s summer house, flooding it with sun — and vibrant decor — during the dark Danish winter ...
A.P. Moeller-Maersk said it is initiating a share-buyback program of up to 14.4 billion danish Krona ($2 billion) over a period of 12 months. The Danish shipping giant on Wednesday said that the first ...
Novo Nordisk shares rose 4.5% after a strong Q4 profit beat, driven by high demand for obesity drug Wegovy, despite forecasting slower sales growth for 2025.
The Danish jeweler expects 7 to 8 percent organic growth for 2025, while keeping a close watch on silver prices.
13h
Hosted on MSNNovo Nordisk Stock Jumps On Q4 Beat: Retail Brushes Off Slower Growth Outlook To Chase Obesity Drug BoomNYSE-listed shares of Novo Nordisk surged 4% on Wednesday morning after the Danish pharmaceutical giant posted ...
Novo Nordisk has a dominant position in diabetes and weight-loss drugs, strong financial growth outlook, and great potential. Click to read why NVO is a Strong Buy.
Banreservas grew its factoring portfolio by 63.5% in 2024 over the previous year. The bank also launched “Factoring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results